# clm_BEE2EE1A4F91

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: -62,505,000 United States dollar  
valid_from: 2011-06-30  
valid_to: 2011-09-30  
published: 2011-07-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_FBBAE356E784  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly net income: -62,505,000 United States dollar", as of 2011-06-30 (until 2011-09-30). Claim clm_BEE2EE1A4F91, https://asof.is/claim/clm_BEE2EE1A4F91, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q2 FY2011, filed 2011-07-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm (primary, SEC EDGAR 10-Q Q2 FY2011, published 2011-07-28)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -43,447,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_BEE2EE1A4F91](/claim/clm_BEE2EE1A4F91.md) | [clm_EBB8DD46F73B](/claim/clm_EBB8DD46F73B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.